A citation-based method for searching scientific literature

Marian J Mourits, G H de Bock. Am Soc Clin Oncol Educ Book 2017
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
Qing Zhang, Guohong Hu, Qifeng Yang, Ruifen Dong, Xing Xie, Ding Ma, Keng Shen, Beihua Kong. Gynecol Oncol 2013
44
100

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
353
100

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
100

Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.
Xianliang Cheng, Lei Zhang, Yajuan Chen, Chen Qing. J Ovarian Res 2017
41
100

Brush cytology of the fallopian tube and implications in ovarian cancer screening.
Deirdre Lum, Richard Guido, Erika Rodriguez, Ted Lee, Suketu Mansuria, Lori D'Ambrosio, R Marshall Austin. J Minim Invasive Gynecol 2014
12
100

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
446
100

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons,[...]. Gut 2017
237
100

Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
Arthur C Fleischer, Andrej Lyshchik, Rochelle F Andreotti, Misun Hwang, Howard W Jones, David A Fishman. AJR Am J Roentgenol 2010
32
100

The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis.
Ho Kyung Sung, Seung Hyun Ma, Ji-Yeob Choi, Yunji Hwang, Choonghyun Ahn, Byoung-Gie Kim, Yong-Man Kim, Jae Weon Kim, Sokbom Kang, Jaehoon Kim,[...]. J Prev Med Public Health 2016
26
100

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
100

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
215
100


Autoantibodies: Opportunities for Early Cancer Detection.
Isabel K Macdonald, Celine B Parsy-Kowalska, Caroline J Chapman. Trends Cancer 2017
47
100

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
196
100

MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
Carlos Palma Flores, Raúl García-Vázquez, Dolores Gallardo Rincón, Erika Ruiz-García, Horacio Astudillo de la Vega, Laurence A Marchat, Yarely M Salinas Vera, César López-Camarillo. Int J Oncol 2017
29
100

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
422
100

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.
Mark H Greene, Marion Piedmonte, Dave Alberts, Mitchell Gail, Martee Hensley, Zoe Miner, Phuong L Mai, Jennifer Loud, Gustavo Rodriguez, Jack Basil,[...]. Cancer Epidemiol Biomarkers Prev 2008
70
100

Mucinous Ovarian Carcinoma.
Philippe Morice, Sebastien Gouy, Alexandra Leary. N Engl J Med 2019
47
100

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Steven J Skates, Mark H Greene, Saundra S Buys, Phuong L Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez, John O Schorge, Mark Sherman, Mary B Daly,[...]. Clin Cancer Res 2017
53
100

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
S J Skates, F J Xu, Y H Yu, K Sjövall, N Einhorn, Y Chang, R C Bast, R C Knapp. Cancer 1995
150
100



Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening.
John Rensselaer van Nagell, Rachel Ware Miller, Christopher P DeSimone, Frederick R Ueland, Iwona Podzielinski, Scott T Goodrich, Jeff W Elder, Bin Huang, Richard J Kryscio, Edward John Pavlik. Obstet Gynecol 2011
65
100

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
100

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
Phuong L Mai, Marion Piedmonte, Paul K Han, Richard P Moser, Joan L Walker, Gustavo Rodriguez, John Boggess, Thomas J Rutherford, Oliver Zivanovic, David E Cohn,[...]. Gynecol Oncol 2017
15
100

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
715
100

Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
Renée Turzanski Fortner, Antje Damms-Machado, Rudolf Kaaks. Gynecol Oncol 2017
35
100

Early detection of ovarian cancer.
Partha M Das, Robert C Bast. Biomark Med 2008
43
100

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
100

Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
Natalie L Adolphi, Kimberly S Butler, Debbie M Lovato, T E Tessier, Jason E Trujillo, Helen J Hathaway, Danielle L Fegan, Todd C Monson, Tyler E Stevens, Dale L Huber,[...]. Contrast Media Mol Imaging 2012
38
100

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
Archana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, Andy Ryan, Margie N Sutton, Keith Baggerly, Hui Zheng, Karen H Lu, Ian Jacobs, Steven Skates,[...]. Cancer Prev Res (Phila) 2019
8
100

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Lauren C Peres, Kara L Cushing-Haugen, Martin Köbel, Holly R Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M Schildkraut, Jennifer A Doherty. J Natl Cancer Inst 2019
127
100

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
100

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
M Esteller, J M Silva, G Dominguez, F Bonilla, X Matias-Guiu, E Lerma, E Bussaglia, J Prat, I C Harkes, E A Repasky,[...]. J Natl Cancer Inst 2000
814
100

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Paul F Pinsky, Kelly Yu, Barnett S Kramer, Amanda Black, Saundra S Buys, Edward Partridge, John Gohagan, Christine D Berg, Philip C Prorok. Gynecol Oncol 2016
56
100

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy.
Hao Chen, Robert Klein, Stacy Arnold, Setsuko Chambers, Wenxin Zheng. Cancer Cell Int 2016
8
100


A randomized study of screening for ovarian cancer: a multicenter study in Japan.
H Kobayashi, Y Yamada, T Sado, M Sakata, S Yoshida, R Kawaguchi, S Kanayama, H Shigetomi, S Haruta, Y Tsuji,[...]. Int J Gynecol Cancer 2008
153
100

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
100

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Claudia Allemani, Hannah K Weir, Helena Carreira, Rhea Harewood, Devon Spika, Xiao-Si Wang, Finian Bannon, Jane V Ahn, Christopher J Johnson, Audrey Bonaventure,[...]. Lancet 2015
100

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
320
100

Germline RAD51C mutations confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Elise Ruark, Rosa Maria Munoz Xicola, Emma Ramsay, Deborah Hughes, Margaret Warren-Perry, Katie Snape, Diana Eccles, D Gareth Evans,[...]. Nat Genet 2012
166
100

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
100

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
100

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
Wei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, Andy Ryan, Evangelia Ourania Fourkala, Zhen Lu, Keith A Baggerly, Yang Zhao, Karen H Lu, David Bowtell,[...]. Clin Cancer Res 2017
30
100

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection.
Hao Chen, Robert Klein, Stacy Arnold, Yiying Wang, Setsuko Chambers, Wenxin Zheng. J Vis Exp 2017
5
100

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.
Kevin M Elias, Wojciech Fendler, Konrad Stawiski, Stephen J Fiascone, Allison F Vitonis, Ross S Berkowitz, Gyorgy Frendl, Panagiotis Konstantinopoulos, Christopher P Crum, Magdalena Kedzierska,[...]. Elife 2017
55
100

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
470
100


Value of three-dimensional contrast-enhanced ultrasound in the diagnosis of small adnexal masses.
Hong Xiang, Rui Huang, Jingxin Cheng, Shahai Gulinaer, Rong Hu, Yuling Feng, Hui Liu. Ultrasound Med Biol 2013
18
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.